Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 84

Sort by

Sort Order Select

Journal Articles

Mid-treatment CSF ctdna and MYD88 clearance outperform PET-CT in predicting response and survival to orelabrutinib-based induction in newly diagnosed PCNSL: A prospective biomarker study

Lixia Sheng, Yanli Lai, Sheng Nie, Yuning Pan, Di Wang, Shanhao Tang, Kaihong Xu, Yongcheng Sun, Ping Zhang, Binbin Lai, Lieguang Chen, Guifang Ouyang

Blood (2025) 146 (Supplement 1): 59.

https://doi.org/10.1182/blood-2025-59

Published: 2025

Journal Articles

A novel BCL-2 inhibitor, bda-366, targets the TLR4 pathway to induce leukemic cell differentiation in venetoclax-resistant RAS-mutated monocytic leukemia

Xiaohui Zhang, Lixin Wu, Ping Zhang, Jia Feng, Xiaojun Huang, Hongyu Zhang

Blood (2025) 146 (Supplement 1): 5054.

https://doi.org/10.1182/blood-2025-5054

Published: 2025

Journal Articles

Efficacy and safety observation of luspatercept for refractory anemia associated with hematologic malignanciesluspatercept治疗血液系统恶性肿瘤相关难治性贫血的疗效和安全性观察luspatercept 改善与血液系统恶性肿瘤相关的难治性贫血的疗效和安全性：一项观察

Ping Zhang, Shuling Yu, Shengfa Gao, Huiling Zhu, Shanhao Tang, Yongcheng Sun, Binbin Lai, Xiao Wu, Lieguang Chen, Kaihong Xu, Lixia Sheng, Guifang Ouyang

Blood (2025) 146 (Supplement 1): 2888.

https://doi.org/10.1182/blood-2025-2888

Published: 2025

Journal Articles

Clinical efficacy of allogeneic hematopoietic stem cell transplantation in infant acute leukemia

Ruijuan Sun, Min Xiong, Zhijie Wei, Deyan Liu, Jian-Ping Zhang, Jiarui Zhou, Xingyu Cao, Yue Lu, Yanli Zhao, Peihua Lu

Blood (2025) 146 (Supplement 1): 6053.

https://doi.org/10.1182/blood-2025-6053

Published: 2025

Journal Articles

IFNγ-driven MHC class II expression by intestinal epithelial cells dictates local cytolytic Th1 cell differentiation and intestinal stem cell loss

Motoko Koyama, Albert Yeh, Kathleen Ensbey, Shruti Bhise, Iona Schuster, Samuel Legg, Ethan Nelson, Tomoko Sekiguchi, Nicole Nemychenkov, Shuichiro Takahashi, Ping Zhang, Simone Minnie, Francoise Haeseleer, Daniel Hippe, Mariapia Degli-Esposti, Scott Furlan, Geoff Hill

Blood (2025) 146 (Supplement 1): 159.

https://doi.org/10.1182/blood-2025-159

Published: 2025

Journal Articles

Single-center retrospective analysis of maribavir in the treatment of refractory and drug-intolerant cytomegalovirus viremia and cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation

Wei Ma, Xingyu Cao, Jiarui Zhou, Jian-Ping Zhang, Yue Lu, Ruijuan Sun, Zhijie Wei, Deyan Liu, Yanli Zhao, Min Xiong, Peihua Lu

Blood (2025) 146 (Supplement 1): 6059.

https://doi.org/10.1182/blood-2025-6059

Published: 2025

Journal Articles

Impact of germline and somatic TP53 mutations on allogeneic HSCT outcomes in hematologic malignancies

Xingyu Cao, Yang Zhang, Lili Yuan, Yue Lu, Jian-Ping Zhang, Zhijie Wei, Deyan Liu, Min Xiong, Yanli Zhao, Jiarui Zhou, Ruijuan Sun, Mengyuan Niu, Fangmin Pan, Jing Long, Peihua Lu

Blood (2025) 146 (Supplement 1): 7786.

https://doi.org/10.1182/blood-2025-7786

Published: 2025

Journal Articles

Multi-omics profiling of the gut Microbiota–Metabolism–Immunity axis reveals predictive biomarkers of treatment response and survival in diffuse large B-cell lymphoma

Blood (2025) 146 (Supplement 1): 3533.

https://doi.org/10.1182/blood-2025-3533

Published: 2025

Journal Articles

Enhanced long-term outcomes with third-party unrelated cord blood co-infusion in a 122-patients cohort undergoing second allo-HSCT for AML in remission

Wei Zhao, Xingyu Cao, Yue Lu, Jian-Ping Zhang, Zhijie Wei, Deyan Liu, Min Xiong, Jiarui Zhou, Ruijuan Sun, Yanli Zhao, Peihua Lu

Blood (2025) 146 (Supplement 1): 4262.

https://doi.org/10.1182/blood-2025-4262

Published: 2025

Journal Articles

Long-term outcomes of allo-HSCT in SET::CAN-positive Hematological Malignancies: A 12-year single-center Study of 36 patients

Xiaomei Liu, Jing Long, Deyan Liu, Jian-Ping Zhang, Yue Lu, Zhijie Wei, Yanli Zhao, Xingyu Cao, Min Xiong, Jiarui Zhou, Ruijuan Sun, Fangmin Pan, Mengyuan Niu, Peihua Lu

Blood (2025) 146 (Supplement 1): 2482.

https://doi.org/10.1182/blood-2025-2482

Published: 2025

Journal Articles

Oral iptacopan demonstrates efficacy as salvage therapy for high-risk transplant-associated thrombotic microangiopathy: First real-world experience

Fei Gao, Qi Wen, Jian-Ping Zhang, Yuanyuan Zhang, Na Xu, Yeqian Zhao, Jimin Shi, He Huang, Xiaofan Li, Yang Cao, Weijie Cao, Xiaodong Mo, Yanmin Zhao

Blood (2025) 146 (Supplement 1): 2431.

https://doi.org/10.1182/blood-2025-2431

Published: 2025

Journal Articles

Allo-HSCT mitigates the prognostic differences between bZIP and non-bZIP CEBPA mutations in AML: A long-term follow-up study of lu daopei hospital

Yanli Zhao, Yue Lu, Deyan Liu, Jian-Ping Zhang, Zhijie Wei, Xingyu Cao, Ruijuan Sun, Min Xiong, Jiarui Zhou, Jing Long, Tong Wang, Hongxing Liu, Peihua Lu

Blood (2025) 146 (Supplement 1): 6049.

https://doi.org/10.1182/blood-2025-6049

Published: 2025

Journal Articles

Ruxolitinib and interferon alfa induce superior rates of complete peripheral blood count remission compared to anagrelide in hydroxyurea-exposed essential thrombocythemia

Tripura Vithala, Seungyeon Lee, Haley Roberts, Shivani Handa, Jennifer Vaughn, Sarah Wall, Ping Zhang, Andrew Srisuwananukorn

Blood (2025) 146 (Supplement 1): 3824.

https://doi.org/10.1182/blood-2025-3824

Published: 2025

Journal Articles

Allogeneic hematopoietic stem cell transplantation in sil::TAL1-positive T-ALL: Prognostic impact of pre-transplant remission and molecular status

Xiao-hong Liu, Jing Long, Jiarui Zhou, Min Xiong, Xingyu Cao, Jian-Ping Zhang, Yue Lu, Zhijie Wei, Yanli Zhao, Ruijuan Sun, Fangmin Pan, Peihua Lu, Deyan Liu

Blood (2025) 146 (Supplement 1): 2502.

https://doi.org/10.1182/blood-2025-2502

Published: 2025

Journal Articles

Optimizing letermovir timing: Day +5 to +8 post haplo-HSCT minimizes EBV dnaemia without compromising CMV prophylaxis

Xingyu Cao, Yue Lu, Jian-Ping Zhang, Zhijie Wei, Deyan Liu, Min Xiong, Yanli Zhao, Jiarui Zhou, Ruijuan Sun, Mengyuan Niu, Fangmin Pan, Jing Long, Peihua Lu

Blood (2025) 146 (Supplement 1): 2500.

https://doi.org/10.1182/blood-2025-2500

Published: 2025

Journal Articles

The impact of HLA loss of heterozygosity on outcome after haploidentical hematopoietic stem cell transplantation in hematological malignancies

Xingyu Cao, Jian-ling Wang, Yanli Zhao, Min Xiong, Yue Lu, Ruijuan Sun, Jian-Ping Zhang, Deyan Liu, Jiarui Zhou, Zhijie Wei, Peihua Lu

Blood (2025) 146 (Supplement 1): 2498.

https://doi.org/10.1182/blood-2025-2498

Published: 2025

Journal Articles

No reduction in gvhd risk for aplastic anemia patients to combined third-party unrelated cord blood in haploidentical hematopoietic stem cells transplantation

Wei Zhao, Xingyu Cao, Yue Lu, Jian-Ping Zhang, Zhijie Wei, Deyan Liu, Min Xiong, Jiarui Zhou, Ruijuan Sun, Jing Long, Peihua Lu, Yanli Zhao

Blood (2025) 146 (Supplement 1): 2495.

https://doi.org/10.1182/blood-2025-2495

Published: 2025

Journal Articles

Multi-hit TP53 mutation is an independent adverse prognostic factor in allogeneic hematopoietic stem cell transplantation for acute leukemia and myelodysplastic syndromes

Yanli Zhao, Yue Lu, Deyan Liu, Jian-Ping Zhang, Zhijie Wei, Xingyu Cao, Ruijuan Sun, Jiarui Zhou, Min Xiong, Jing Long, Tong Wang, Peihua Lu

Blood (2025) 146 (Supplement 1): 2493.

https://doi.org/10.1182/blood-2025-2493

Published: 2025

Journal Articles

CD3⁺cell dose is an independent risk factor for grade II–IV aGVHD following cord blood transplantation in children with aplastic anemia

Jian-Ping Zhang, Li Nannan, Min Xiong, Jing Long, Xingyu Cao, Yue Lu, Zhijie Wei, Deyan Liu, Ruijuan Sun, Jiarui Zhou, Yanli Zhao, Jun-bao He, Peihua Lu

Blood (2025) 146 (Supplement 1): 7752.

https://doi.org/10.1182/blood-2025-7752

Published: 2025

Journal Articles

Timed PD-1 blockade synergizes with IL-7/CCL19 armoring to reverse CAR-T exhaustion in PD-L1-high large B-cell lymphoma

Lixia Sheng, Wen Lei, Duo Wu, Yi Zhang, Yanli Lai, Shuyan Wang, Duobing Zou, Ping Zhang, Kaihong Xu, Shanhao Tang, Huijie Hu, Tongyu Li, Qitian Mu, Xiaofei Ye, Hui Liu, Wenbin Qian, Guifang Ouyang

Blood (2025) 146 (Supplement 1): 1929.

https://doi.org/10.1182/blood-2025-1929

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Mid-treatment CSF ctdna and MYD88 clearance outperform PET-CT in predicting response and survival to orelabrutinib-based induction in newly diagnosed PCNSL: A prospective biomarker study

A novel BCL-2 inhibitor, bda-366, targets the TLR4 pathway to induce leukemic cell differentiation in venetoclax-resistant RAS-mutated monocytic leukemia

Clinical efficacy of allogeneic hematopoietic stem cell transplantation in infant acute leukemia

IFNγ-driven MHC class II expression by intestinal epithelial cells dictates local cytolytic Th1 cell differentiation and intestinal stem cell loss

Single-center retrospective analysis of maribavir in the treatment of refractory and drug-intolerant cytomegalovirus viremia and cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation

Impact of germline and somatic TP53 mutations on allogeneic HSCT outcomes in hematologic malignancies

Multi-omics profiling of the gut Microbiota–Metabolism–Immunity axis reveals predictive biomarkers of treatment response and survival in diffuse large B-cell lymphoma

Enhanced long-term outcomes with third-party unrelated cord blood co-infusion in a 122-patients cohort undergoing second allo-HSCT for AML in remission

Long-term outcomes of allo-HSCT in SET::CAN-positive Hematological Malignancies: A 12-year single-center Study of 36 patients

Oral iptacopan demonstrates efficacy as salvage therapy for high-risk transplant-associated thrombotic microangiopathy: First real-world experience

Allo-HSCT mitigates the prognostic differences between bZIP and non-bZIP CEBPA mutations in AML: A long-term follow-up study of lu daopei hospital

Ruxolitinib and interferon alfa induce superior rates of complete peripheral blood count remission compared to anagrelide in hydroxyurea-exposed essential thrombocythemia

Allogeneic hematopoietic stem cell transplantation in sil::TAL1-positive T-ALL: Prognostic impact of pre-transplant remission and molecular status

Optimizing letermovir timing: Day +5 to +8 post haplo-HSCT minimizes EBV dnaemia without compromising CMV prophylaxis

The impact of HLA loss of heterozygosity on outcome after haploidentical hematopoietic stem cell transplantation in hematological malignancies

No reduction in gvhd risk for aplastic anemia patients to combined third-party unrelated cord blood in haploidentical hematopoietic stem cells transplantation

Multi-hit TP53 mutation is an independent adverse prognostic factor in allogeneic hematopoietic stem cell transplantation for acute leukemia and myelodysplastic syndromes

CD3⁺cell dose is an independent risk factor for grade II–IV aGVHD following cord blood transplantation in children with aplastic anemia

Timed PD-1 blockade synergizes with IL-7/CCL19 armoring to reverse CAR-T exhaustion in PD-L1-high large B-cell lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only